TickerFacts.

A business in context

URGN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-26 · 0001437749-26-029175

  2. 4 · Ownership change

    Report date 2026-08-20 · 0001437749-26-028840

  3. 8-K · Current report

    Report date 2026-08-18 · 0001437749-26-028590 · Items 8.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-025794

  5. 8-K · Current report

    Report date 2026-08-05 · 0001437749-26-025793 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-07-09 · 0001437749-26-023290

  7. 4 · Ownership change

    Report date 2026-06-22 · 0001437749-26-021523

  8. 4 · Ownership change

    Report date 2026-06-22 · 0001437749-26-021519

  9. 4 · Ownership change

    Report date 2026-06-22 · 0001437749-26-021517

  10. 4 · Ownership change

    Report date 2026-06-22 · 0001437749-26-021515

  11. 4 · Ownership change

    Report date 2026-06-22 · 0001437749-26-021513

  12. 8-K · Current report

    Report date 2026-06-22 · 0001437749-26-021442 · Items 3.03,5.02,5.07,9.01

  13. 8-K · Current report

    Report date 2026-06-02 · 0001437749-26-019102 · Items 8.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015019

  15. 8-K · Current report

    Report date 2026-05-06 · 0001437749-26-015018 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001437749-26-014237

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-006234

  18. 8-K · Current report

    Report date 2026-03-02 · 0001437749-26-006233 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-084282 · Items 1.01,2.03

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-033468

  21. 8-K · Current report

    Report date 2025-11-06 · 0001437749-25-033466 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-08-26 · 0001437749-25-027874 · Items 5.02,5.07,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-025243

  24. 8-K · Current report

    Report date 2025-08-07 · 0001437749-25-025242 · Items 2.02,9.01

  25. DEF 14A · Proxy statement

    Report date 2025-08-11 · 0001437749-25-022732

  26. 8-K · Current report

    Report date 2025-06-30 · 0001193125-25-155503 · Items 5.02

  27. 8-K · Current report

    Report date 2025-06-12 · 0001193125-25-140339 · Items 8.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-015956

  29. 8-K · Current report

    Report date 2025-05-12 · 0001437749-25-015955 · Items 2.02,9.01

  30. 10-K/A · Annual report

    Report date 2024-12-31 · 0001437749-25-013839

  31. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-006842

  32. 8-K · Current report

    Report date 2025-03-10 · 0001437749-25-006757 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-02-14 · 0001193125-25-030143 · Items 1.01,3.02

  34. 8-K · Current report

    Report date 2025-01-14 · 0001193125-25-005649 · Items 7.01,9.01

  35. SC 13D/A · Ownership disclosure

    0001213900-24-099322

  36. SC 13G/A · Ownership disclosure

    0001178913-24-003701

  37. SC 13G/A · Ownership disclosure

    0001172661-24-005288

  38. SC 13G/A · Ownership disclosure

    0001104659-24-119305

  39. SC 13G/A · Ownership disclosure

    0000902664-24-006639

  40. SC 13G/A · Ownership disclosure

    0000902664-24-006499

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 10 transaction rows10AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

17 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-22
2026-06-24
Schoenberg Mark
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares10000.035.01
2026-06-22
2026-06-24
Wildman Daniel GeorgeA · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
10000.00.0
2026-06-22
2026-06-24
Wildman Daniel GeorgeA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
8000.00.0
2026-06-22
2026-06-24
Robinson James A. Jr.A · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
10000.00.0
2026-06-22
2026-06-24
Robinson James A. Jr.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
8000.00.0
2026-06-22
2026-06-24
Holden StuartA · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
20000.00.0
2026-06-22
2026-06-24
BUTITTA CYNTHIA MA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
8000.00.0
2026-06-22
2026-06-24
BUTITTA CYNTHIA MA · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
10000.00.0
2026-06-22
2026-06-24
WEN LEANAA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
8000.00.0
2026-06-22
2026-06-24
WEN LEANAA · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
10000.00.0
2026-06-22
2026-06-24
Belldegrun ArieA · Grant / award
Acquired
Stock Option (right ot buy)
Derivative security
20000.00.0
2026-06-08
2026-06-09
Schoenberg MarkS · Sale
Disposed
Ordinary Shares5222.027.3
2026-06-08
2026-06-09
Schoenberg MarkM · Exercise / conversion
Acquired
Ordinary Shares10000.0—
2026-06-08
2026-06-09
Schoenberg MarkM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
10000.00.0
2026-05-26
2026-05-27
Robinson James A. Jr.M · Exercise / conversion
Acquired
ordinary shares2000.0—
2026-05-26
2026-05-27
Robinson James A. Jr.M · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
2000.00.0
2026-05-08
2026-05-11
Schoenberg Mark
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares10000.030.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001668243UroGen Pharma Ltd.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$90.40M$96.23M
    2023-12-31$82.71M$90.64M
    2022-12-31$64.36M$73.42M
    2021-12-31$48.04M$59.19M
    2020-12-31$11.80M$15.22M
    2019-12-31$18.0K$23.5K
    2018-12-31$1.13M$1.50M
    2017-12-31$8.16M$11.11M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗